百奥赛图-B 港股通 空最新增减持 (2026-07-23) 官网 ( 02315.hk) | 68.94 | 8.65 | 0% | 上市时间2022-09-01股价50.15港币涨跌幅4.13%成交金额1.02亿港币换手率0.45%市值224.12亿港币H股市值55.56亿港币总股本4.47亿H股本1.11亿每手股数500上市至今年化投资收益率18.28%港股通持仓占H股比例40.07% (23.35亿港币2026-07-29) 累计做空占H股比例2.11% (1.21亿港币2026-07-24) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 119.88 | 市净率 | 4.37 | 股息率 | 0.38% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 备注 (5): | 双击编辑备注 |
百奥赛图-B(02315) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 張蕾娣 | Non Executive Director | 2022-11-07 | -- | |
| 2 | 華風茂 | Independent Non Executive Director | 2021-07-05 | -- | |
| 3 | 梁曉燕 | Independent Non Executive Director - A/F | 2020-12-15 | -- | |
| 4 | 喻長遠 | Independent Non Executive Director | 2020-12-15 | -- | |
| 5 | 張海超 | Executive Director | 2019-07-24 | -- | |
| 6 | 黃小魯 | Non Executive Director | 2019-07-24 | 2022-11-07 | |
| 7 | 周可祥 | Non Executive Director | 2018-03-09 | -- | |
| 8 | 魏義良 | Non Executive Director | 2015-09-30 | -- | |
| 9 | 倪健 | Executive Director | 2009-11-13 | -- | |
| 10 | 沈月雷 | Executive Director | Chairman, CEO | 2009-11-13 | -- |